On this episode, host Fred Goldstein invites Franck Rahaghi, MD, MHS, Executive Director of Cardiopulmonary Global Medical Affairs at United Therapeutics, about pulmonary hypertension in interstitial lung disease (PH-ILD), a serious and often under-recognized condition at the intersection of two progressive diseases. We discuss the importance of early recognition, the role of multidisciplinary care, emerging treatment options, and what patients, clinicians, and payers should know to improve outcomes.
Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen/